Coherus BioSciences, Inc. is a company in the U.S. stock market and it is a holding in 59 U.S.-traded ETFs. CHRS has around 13.4M shares in the U.S. ETF market. The largest ETF holder of CHRS is the iShares Core S&P Small-Cap ETF (IJR), with approximately 3.77M shares. Investors may also find of interest that the ETF with the largest allocation to CHRS stock is Invesco Dynamic Biotechnology & Genome ETF (PBE), with a portfolio weight of 2.50%. On average, U.S. ETFs allocate 0.21% of CHRS to their portfolios.
Additionally, CHRS is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CHRS as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 46.99%.